Madison, WI, United States of America

Terrance M Henker

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2018-2019

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Terrance M. Henker: Innovator in Recombinant Protein Production

Introduction

Terrance M. Henker is a notable inventor based in Madison, WI (US). He has made significant contributions to the field of biotechnology, particularly in the production of recombinant proteins. With a total of 2 patents, his work has implications for various applications in medicine and research.

Latest Patents

Henker's latest patents include advancements in the enhanced production of recombinant CRM197. This innovation involves reduced genome or native K12 strain bacteria that comprise expression vectors encoding a recombinant CRM197 protein. The CRM197 protein may be fused to a signal sequence that directs the expressed protein to the periplasm of the host. Additionally, he has developed bacteria with improved metabolic capacity, which includes genetic modifications to enhance fermentability and the production of proteins and nucleic acids.

Career Highlights

Terrance M. Henker has established himself as a key figure in the biotechnology sector. His work at Scarab Genomics, LLC has allowed him to focus on innovative solutions that address challenges in protein production. His patents reflect a commitment to advancing the field and improving methodologies for recombinant protein synthesis.

Collaborations

Henker has collaborated with esteemed colleagues such as Frederick R. Blattner and David A. Frisch. These partnerships have fostered an environment of innovation and have contributed to the success of his projects.

Conclusion

Terrance M. Henker's contributions to biotechnology through his patents and collaborations highlight his role as an innovator in the field. His work continues to influence the production of recombinant proteins, paving the way for future advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…